logo-loader
viewAvacta Group PLC

Avacta's Alastair Smith encouraged by significant progress and share price momentum

Alastair Smith, chief executive of Avacta Group PLC (LON:AVCT), caught up with Proactive London's Andrew Scott to talk through a business update released from the firm to coincide with its annual general meeting this week.

Among recent highlights were the partnership with LG Chem, which sent the company’s shares soaring in December, and the research collaboration with leading scientists at Tufts University Medical School.

The company also announced a licensing deal last year with New England Biolabs and appointed Jose Saro as the chief medical officer.

Quick facts: Avacta Group PLC

Price: 27.05714 GBX

AIM:AVCT
Market: AIM
Market Cap: £47.63 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Twenty Seven Co aims to extend Rover gold discovery with...

Twenty Seven Co Ltd (ASX:TSC) chief executive officer Ian Warland updates Proactive on the approval of a follow-up RC drilling campaign at Rover Project in WA aimed at extending the gold discovery. The company has secured regulatory approval for the next drilling phase to commence in early...

5 hours, 16 minutes ago

2 min read